2seventy bio, Inc. (NASDAQ:TSVT) Given Average Rating of “Moderate Buy” by Analysts

2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, four have assigned a buy recommendation and one […]

Leave a Reply

Your email address will not be published.

Previous post American Axle & Manufacturing Holdings, Inc. (NYSE:AXL) Given Average Recommendation of “Hold” by Brokerages
Next post Adaptive Biotechnologies Co. (NASDAQ:ADPT) Receives $6.80 Average Price Target from Brokerages